A. A. Lover, J. K. Baird, R. Gosling, and R. Price, Malaria elimination: Time to target all species, Am J Trop Med Hyg, 2018.

J. K. Baird, K. E. Battle, and R. E. Howes, Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms, Malar J, vol.17, p.42, 2018.

R. E. Howes, F. B. Piel, A. P. Patil, O. A. Nyangiri, P. W. Gething et al., G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map, PLoS Med, vol.9, issue.11, p.1001339, 2012.

E. T. Nkhoma, C. Poole, V. Vannappagari, S. A. Hall, and E. Beutler, The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis. Blood Cells, Molecules and Diseases, vol.42, pp.267-78, 2009.

L. Luzzatto and P. Arese, Favism and glucose-6-phosphate dehydrogenase deficiency, N Engl J Med, vol.378, issue.1, pp.60-71, 2018.

K. D. Belfield and E. M. Tichy, Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency, Am J Health Syst Pharm, vol.75, issue.3, pp.97-104, 2018.

G. J. Domingo, N. Advani, A. W. Satyagraha, C. H. Sibley, E. Rowley et al., Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities, Int Health, vol.11, issue.1, pp.7-14, 2018.

S. Gómez-manzo, J. Marcial-quino, A. Vanoye-carlo, H. Serrano-posada, D. Ortega-cuellar et al., Glucose-6-phosphate dehydrogenase: Update and analysis of new mutations around the world, Int J Mol Sci, vol.17, issue.12, p.2069, 2016.

A. Minucci, K. Moradkhani, M. J. Hwang, C. Zuppi, B. Giardina et al., Glucose-6-phosphate dehydrogenase (G6PD) mutations database: Review of the "old" and update of the new mutations, Blood Cells Mol Dis, vol.48, issue.3, pp.154-65, 2012.

L. Luzzatto, Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica, vol.91, p.1303, 2006.

A. D. Cunningham, A. Colavin, K. C. Huang, and D. Mochly-rosen, Coupling between protein stability and catalytic activity determines pathogenicity of G6PD variants, Cell Rep, vol.18, issue.11, pp.2592-2601, 2017.

B. Ley, G. Bancone, L. Von-seidlein, K. Thriemer, J. S. Richards et al., Methods for the field evaluation of quantitative G6PD diagnostics: a review, Malar J, vol.16, issue.1, p.28893237, 2017.

S. Pal, P. Bansil, G. Bancone, S. Hrutkay, M. Kahn et al., Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient, Am J Trop Med Hyg, 2018.

M. S. Alam, M. G. Kibria, N. Jahan, R. N. Price, and B. Ley, Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation, BMC Res Notes, vol.11, issue.1, p.30514365, 2018.

E. Beutler, K. G. Blume, J. C. Kaplan, G. W. Lö-hr, B. Ramot et al., International Committee for Standardization in Haematology: Recommended Methods for Red-Cell Enzyme Analysis, Br J Haematol, vol.35, issue.2, pp.331-371, 1977.

G. J. Domingo, A. W. Satyagraha, A. Anvikar, K. Baird, G. Bancone et al., G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests, Malar J, vol.12, issue.1, p.24188096, 2013.

, World Health Organization. Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale malaria, 2016.

M. Lacerda, A. Llanos-cuentas, S. Krudsood, L. C. Saunders, D. L. Mohammed et al., Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria, N Engl J Med, vol.380, issue.3, pp.215-243, 2019.

A. Llanos-cuentas, M. Lacerda, T. T. Hien, . Vé, . Id et al., Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria, N Engl J Med, vol.380, issue.3, pp.229-270, 2019.

G. Henriques, K. Phommasone, R. Tripura, T. J. Peto, S. Raut et al., Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia, Malar J, vol.17, issue.1, p.29929514, 2018.

P. F. Whiting, A. Rutjes, M. E. Westwood, S. Mallett, J. J. Deeks et al., QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, vol.155, issue.8, pp.529-565, 2011.

, World Health Organization. Technical specifications series for submission to WHO prequalificationdiagnostic assessment: in vitro diagnostic medical devices to identify glucose-6-phosphate dehydrogenase (G6PD) activity. Geneva: World Health Organization, 2016.

H. Wickham and . Tidyverse, Easily install and load the 'tidyverse, 2017.

H. Wickham, Elegant graphics for data analysis, 2009.

C. O. Wilke, cowplot: Streamlined plot theme and plot annotations for 'ggplot2, 2019.

M. Stevenson and . Epir, Tools for the analysis of epidemiological, 2018.

. R-core-team, R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing, 2018.

G. Bancone, C. S. Chu, N. Chowwiwat, R. Somsakchaicharoen, P. Wilaisrisak et al., Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests, Am J Trop Med Hyg, vol.92, issue.4, p.4385780, 2015.

N. N. Oo, G. Bancone, L. Z. Maw, N. Chowwiwat, P. Bansil et al., Validation of G6PD point-ofcare rests among healthy volunteers in Yangon, Myanmar. PLoS ONE, vol.11, issue.4, p.152304, 2016.

A. W. Satyagraha, A. Sadhewa, R. Elvira, I. Elyazar, D. Feriandika et al., Assessment of pointof-care diagnostics for G6PD deficiency in malaria endemic rural Eastern Indonesia, PLoS Negl Trop Dis, vol.10, issue.2, p.4457, 2016.

S. F. Travis, S. P. Kumar, P. C. Paez, and M. Delivoria-papadopoulos, Red cell metabolic alterations in postnatal life in term infants. Glycolytic enzymes and glucose-6-phosphate dehydrogenase, Pediatr Res, vol.14, issue.12, p.1349, 1980.

W. Yang, S. Tai, C. Hsu, C. Fu, A. Chou et al., Reference levels for glucose-6-phosphate dehydrogenase enzyme activity in infants 7-90 days old in Taiwan, J Formos Med Assoc, 2019.

R. Rueangweerayut, G. Bancone, E. J. Harrell, A. P. Beelen, S. Kongpatanakul et al., Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers, Am J Trop Med Hyg, vol.97, issue.3, pp.702-713, 2017.

M. S. Alam, M. G. Kibria, N. Jahan, K. Thriemer, M. S. Hossain et al., Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity, PLoS ONE, vol.13, issue.11, p.206331, 2018.

C. A. Major, L. Pretlow, E. Fincher, and V. Koziatek, Validating the assessment of glucose-6-phosphate dehydrogenase (G6PD), Clin Lab Sci, vol.19, issue.3, pp.134-143, 2006.

. Who-working-group, Glucose-6-phosphate dehydrogenase deficiency, Bull World Health Organ, vol.67, issue.6, pp.601-612, 1989.

R. J. Commons, J. S. Mccarthy, and R. N. Price, Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency, Med J Aust, vol.212, issue.4, pp.152-155, 2020.

P. Charoenkwan, W. Tantiprabha, S. Sirichotiyakul, A. Phusua, and T. Sanguansermsri, Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand, Southeast Asian J of Trop Med Public Health, vol.45, issue.1, pp.187-93, 2014.

M. E. Roh, C. Oyet, P. Orikiriza, M. Wade, J. Mwanga-amumpaire et al., Screening for glucose-6-phosphate dehydrogenase deficiency using three detection methods: A cross-sectional survey in Southwestern Uganda, Am J Trop Med Hyg, vol.95, issue.5, p.27672207, 2016.